A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy


Temurhan S., Akgul S. , Caliskan Y., Artan A. S. , Kekik C., Yazici H. , ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.49, ss.541-545, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background. The serum levels of galactose-deficient immunoglobulin (Ig)A1 (Gd-IgAl) represent the most promising candidate biomarker for IgA nephropathy (IgAN). The aim of this study was to evaluate the serum levels of Gd-IgAl as a novel noninvasive biomarker for post-transplant IgAN recurrence.